Quick Answer
ZEVRA THERAPEUTICS, INC. reported Net Income Loss of $83.23 million for the year ending 2025.
- ZEVRA THERAPEUTICS, INC. showed an increase of +178.9% in Net Income Loss from 2024 to 2025.
- This data is from ZEVRA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: -$9.74 million | Q4 2015: -$9.20 million | Q1 2016: -$2.93 million | Q2 2016: $9.77 million | Q3 2016: -$13.41 million | Q4 2016: -$9.94 million | Q1 2017: -$16.32 million | Q2 2017: -$6.52 million | Q3 2017: -$9.98 million | Q4 2017: -$10.57 million | Q1 2018: -$26.22 million | Q2 2018: -$9.99 million | Q3 2018: -$15.07 million | Q1 2019: -$12.29 million | Q2 2019: -$9.26 million | Q3 2019: $3.06 million | Q1 2020: -$5.75 million | Q2 2020: $859.0 thousand | Q3 2020: -$3.01 million | Q1 2021: -$10.30 million | Q2 2021: $6.20 million | Q3 2021: -$1.76 million | Q1 2022: -$1.86 million | Q2 2022: -$24.04 million | Q3 2022: -$6.62 million | Q1 2023: -$13.22 million | Q2 2023: -$2.57 million | Q3 2023: -$10.37 million | Q1 2024: -$16.62 million | Q2 2024: -$19.93 million | Q3 2024: -$33.23 million | Q1 2025: -$3.10 million | Q2 2025: $74.71 million | Q3 2025: -$544.0 thousand.
- Over the full 13 years of available data (2013 to 2025), ZEVRA THERAPEUTICS, INC.'s Net Income Loss has grown by 1,692.6%.
- Historical annual values: Fiscal year 2025: $83.23 million | Fiscal year 2024: -$105.51 million | Fiscal year 2023: -$46.05 million | Fiscal year 2022: -$26.77 million | Fiscal year 2021: -$8.56 million | Fiscal year 2020: -$12.76 million | Fiscal year 2019: -$24.52 million | Fiscal year 2018: -$56.47 million | Fiscal year 2017: -$43.39 million | Fiscal year 2016: -$16.52 million | Fiscal year 2015: -$54.66 million | Fiscal year 2014: -$24.46 million | Fiscal year 2013: -$5.23 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: